The report on the Global Biochips Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Biochips are microarrays organized on solid substrate that helps in frequent biochemical reactions for instance decode of genes in just few seconds. In addition, biochips work in biological environment and can detect biomarkers and can perform biochemical reactions in few minutes. Developments in biotechnology market has given rise of biochips. Biochips are extensively used in R&D of drugs, molecular diagnosis etc. Hence, these factors have driven the growth of this market. Rising application of biochips in treatment of cancer has augmented the growth of this market. Biochips can detect cancer even before the body develop symptoms of it. In addition, it is used to detect various other diseases such as smallpox, anthrax and plague.
North America is the largest market owing to aged population, rise in lifestyle diseases, and also investments made on research and developments on biochips has propelled the growth of this market. Growing consumption of unhealthy foods and attraction towards urban lifestyle have acted as factors that will impel the growth of this market. Asia Pacific will also witness an augmented growth in the coming years with rising population shifting towards urban cities, higher disposal income, and economic development will boost the growth of this market. Growing focus on healthcare sector, rising medical expenditure in developing nations has bolstered the growth.
Drivers
- Rising demand for personalized medicine
- Increased application of biochips
- Rise in technological developments in biochips industry
Restraints
- Indistinct regulations
- Higher costs for instrumentation
- Absolute quantification of specific mRNA expressions
Report includes a detailed analysis on value chain in order to provide a holistic view of the biochips market. Value chain analysis comprises detailed evaluation of the roles of various players involved in the biochips industry, from raw material suppliers to end-users.
Biochips market attractiveness analysis has been included in order to analyze the application segments that are estimated to be lucrative during the forecast period on the basis of their market size and growth rate. Attractiveness of the market has been derived from market size, profit margin, growth rate, availability of raw materials, competition, and other factors such as social and legal constraints.
The biochips market has further been segmented based on types such as DNA chips, lab-on-a-chip, protein chips, and other arrays. The study provides forecast and estimates market for each type in terms of revenue and volume during the forecast period from 2020 to 2026. Each type has been further analyzed based on regional and country levels from 2019 to 2026 in terms of volume and revenue.
The biochips market has been segmented based on end-user such as biotechnology & pharmaceutical companies, hospitals & diagnostics centers, academic & research institutes, and others (blood banks, CROs, forensic labs, point-of-care settings, patient self-testing, home health agencies, nursing homes, and local public health laboratories). The study provides forecast and estimates market for each end-user in terms of revenue and volume during the forecast period from 2020 to 2026. Each end-user has been further analyzed based on regional and country levels from 2019 to 2026 in terms of volume and revenue.
The biochips market has been segmented based on fabrication technology such as microarrays and microfluidics. The study provides forecast and estimates market for each fabrication technology in terms of revenue and volume during the forecast period from 2020 to 2026. Each fabrication technology has been further analyzed based on regional and country levels from 2019 to 2026 in terms of volume and revenue.
In terms of geography, the biochips market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and Rest of the world. The study provides a detailed view of country-level aspects of the market on the basis of application segments and estimates the market in terms of revenue and volume during the forecast period.
The report also offers a competitive landscape of the overall market with company profiles of players such as:
- Abbott Laboratories
- Agilent Technologies, Inc.
- Perkinelmer, Inc.
- Fluidigm Corporation
- Illumina, Inc.
- GE Healthcare
- Bio-Rad Laboratories Inc.
- Cepheid Inc.
- Thermo Fisher Scientific, Inc.
- Roche Diagnostics
A detailed description of the each company has been included and includes information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments provides a thorough idea about the competitive positioning of market players. The report also provides biochips market's mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.
SEGMENTATIONS IN REPORT:
Biochips Market Analysis By Type:
- DNA Chips
- Lab-On-A-Chip
- Protein Chips
- Other Arrays
Biochips Market Analysis By Fabrication Technology:
- Microarrays
- Microfluidics
Biochips Market Analysis By End User:
- Biotechnology And Pharmaceutical Companies
- Hospitals And Diagnostics Centers
- Academic & Research Institutes
- Others (Blood Banks, CROs, Forensic Labs, Point-Of-Care Settings, Patient Self-Testing, Home Health Agencies, Nursing Homes, And Local Public Health Laboratories)
Biochips Market By Geography:
- North America
- Europe
- Asia Pacific
- Rest of the World
The Global Biochips Market has been exhibited in detail in the following chapters -
Chapter 1 Biochips Market Preface
Chapter 2 Executive Summary
Chapter 3 Biochips Industry Analysis
Chapter 4 Biochips Market Value Chain Analysis
Chapter 5 Biochips Market Analysis By Type
Chapter 6 Biochips Market Analysis By Fabrication Technology
Chapter 7 Biochips Market Analysis By End User
Chapter 8 Biochips Market Analysis By Geography
Chapter 9 Competitive Landscape Of Biochips Companies
Chapter 10 Company Profiles Of Biochips Industry
METHODOLOGY:
Combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific Details on methodology used for this report can be provided on demand.